Schwartz S: Disease of distinction. [http://www.stephanaschwartz.com/PDF/disease_of_distinction.pdf]
Hippocrates: The Genuine Works of Hippocrates. Edited by: Adams F. 1886, New York: Wood, I and II:
Google Scholar
Galen C: Claudii Galeni Opera Omni. 1821, Leipzig: CG Kühn, –1833
Google Scholar
Garrison FH: An Introduction to the History of Medicine. 1929, Philadelphia, PA: Saunders
Google Scholar
Copeman WSC: A Short History of the Gout and the Rheumatic Diseases. 1964, Los Angeles, CA: University of California Press
Google Scholar
Sydenham T: Tractatus de Podagra et Hydrope. 1683, London: G Kettilby
Google Scholar
Lewis WS, editor: Horace Walpole to Sir Horace Mann, 8 May 1873. The Yale Editions of Horace Walpole's Correspondence. 1937, New Haven: Yale University Press, 25: 402- –1983
Google Scholar
Zollner N: Influence of various purines on uric acid metabolism. Bibl Nutr Dieta. 1973, 19: 34-43.
PubMed
Google Scholar
Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G: Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med. 2004, 350: 1093-1103. 10.1056/NEJMoa035700.
Article
CAS
PubMed
Google Scholar
McCarty DJ: A historical note: Leeuwenhoek's description of crystals from a gouty tophus. Arthritis Rheum. 1970, 13: 414-418.
Article
CAS
PubMed
Google Scholar
Stukeley W: Of the Gout. 1734, London: Roberts
Google Scholar
Scheele KW: Examen chemicum calculi urinarii. Opuscula. 1776, 2: 73-
Google Scholar
Woolaston WH: On gouty and urinary concretions. Philosoph Trans R Soc Lond. 1787, 87: 386-415.
Article
Google Scholar
Garrod AB: Observations on certain pathological conditions of the blood and urine in gout, rheumatism and Bright's disease. Trans M-Chir Soc Edinburgh. 1848, 31: 83-97.
CAS
Google Scholar
Garrod AB: The Nature and Treatment of Gout and Rheumatic Gout. 1859, London: Walton and Maberly
Google Scholar
Freudweiler M: Experimentelle untersuchungen uber das wesen der gichtknoten. Dtsch Arch Klin Med. 1899, 63: 266-335.
Google Scholar
His WJ: Schicksal und wirkungendes sauren harnsauren natrons in bauch und gelenkhohle das kaninchens. Dtsch Arch Klin Med. 1900, 67: 81-108.
Google Scholar
McCarty DJ, Hollander JL: Identification of urate crystals in gouty synovial fluid. Ann Intern Med. 1961, 54: 452-460.
Article
CAS
PubMed
Google Scholar
McCarty DJ, Kohn NN, Faires JS: The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the 'pseudogout syndrome'. I. Clinical aspects. Ann Intern Med. 1962, 56: 711-737.
Article
CAS
Google Scholar
Arataeus the Cappadocian: The Extant Works. Edited by: Adams F. 1856, London: The Sydenham Society
Google Scholar
Garrod AE: The Inborn Factors in Disease: An Essay. 1931, London: Oxford University Press
Google Scholar
Seegmiller JE, Rosenbloom FM, Kelley WN: An enzyme defect associated with a sex-linked human neurologigacal disorder and excessive purine synthesis. Science. 1967, 155: 1682-1684.
Article
CAS
PubMed
Google Scholar
Seegmiller JE, Grayzel AI, Laster L, Liddle L: Uric acid production in gout. J Clin Invest. 1961, 40: 1304-1314.
Article
PubMed Central
CAS
PubMed
Google Scholar
Stoerk A: An Essay on the Use and Effects of the Root of the Colchicum autumnale, or Meadow Saffron, Translated from the Latin. 1764, London: T Becket and PA de Honet
Google Scholar
Terkeltaub RA: Clinical Practice. Gout. N Engl J Med. 2003, 349: 1647-1655. 10.1056/NEJMcp030733.
Article
CAS
PubMed
Google Scholar
Garrod AB: A Treatise on Gout and Rheumatic Gout (Rheumatoid Arthritis). 1876, London: Longmans, Green, 3
Google Scholar
Haig A: A contribution to the pathology of high arterial tension, headache, epilepsy, mental depression, gout, rheumatism, diabetes, Bright's disease, and other disorders. Uric Acid as a Factor in the Causation of Disease. 1908, London: J & A Churchill, 12: 940-7
Google Scholar
Griebsch A, Kaiser W: Einfluss exogener purine auf den harnsaurestoffwechsel. Handbuch der Inneren Medizin Bd 7, 5, aufl. 1976, Berlin: Springer
Google Scholar
Kippen I, Whitehouse MW, Klinenberg JR: Pharmacology of uricosuric drugs. Ann Rheum Dis. 1974, 33: 391-396.
Article
PubMed Central
CAS
PubMed
Google Scholar
See G: Etudes sur l'acid salicylique et les salicylates: traitement du rhumatisme aigu et chronique, de la goutte, et de diverses affections du system nerveux sensitive par les salicylates. Bull Acad Med Paris. 1877, 6: 689-706. 717–754, 926–933, 937–943, 1024–1027.
Google Scholar
Yu T-F, Gutman AB: Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest. 1959, 38: 1298-1315.
Article
PubMed Central
CAS
PubMed
Google Scholar
Talbott JH, Bishop C, Norcross M, Lockie LM: The clinical and metabolic effects of benemid in patients with gout. Trans Assoc Am Physicians. 1951, 64: 372-
CAS
PubMed
Google Scholar
Burns JJ, Yu T-F, Ritterband A, Perel JM, Gutman AB, Brodie BB: A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue G-25671. J Pharmacol Exp Ther. 1957, 119: 418-426.
CAS
PubMed
Google Scholar
Delbarre F, Auscher C, Amor B: Action uricosurique de certains derives du benzofuranne. Soc Med Hop Paris. 1965, 116: 1193-1196.
Google Scholar
Kamper AL, Nielsen AH: Uricosuric effect of losartan in patients with renal transplants. Transplantation. 2001, 72: 671-674. 10.1097/00007890-200108270-00019.
Article
CAS
PubMed
Google Scholar
Feher MD, Hepburn AL, Hogarth MB, Ball SG, Kaye SA: Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout. Rheumatology. 2003, 42: 321-325. 10.1093/rheumatology/keg103.
Article
CAS
PubMed
Google Scholar
London M, Hudson PB: Uricolytic activity of purified uricase in two human beings. Science. 1957, 125: 937-938.
Article
CAS
PubMed
Google Scholar
Bosly A, Sonet A, Pinkerton CR, McCowage G, Bron D, Sanz MA, Van den Berg H: Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study. Cancer. 2003, 98: 1048-1054. 10.1002/cncr.11612.
Article
CAS
PubMed
Google Scholar
Rundles RW, Wyngaarden JB, Hitchings GH, Elion GB, Silber-man HR: Effects of a xanthine oxidase inhibitor on thiopurine metabolism, hyperuricaemia and gout. Trans Assoc Am Physicians. 1963, 76: 126-140.
CAS
Google Scholar
Walter-Sack I, de Vries JX, Kutschker C, Ittensohn A, Voss A: Disposition and uric acid lowering effect of oxipurinol: comparison of different oxipurinol formulations and allopurinol in healthy individuals. Eur J Clin Pharmacol. 1995, 49: 215-220. 10.1007/BF00192382.
Article
CAS
PubMed
Google Scholar
Becker MA, Schumacher HR, Wortmann RL, MacDonald PA, Palo WA, Eustace D, Vernillet L, Joseph-Ridge N: Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a 28-day, multicenter, phase II, randomized, double-blind, placebo-controlled dose-response clinical trial examining safety and efficacy in patients with gout. Arthritis Rheum. 2005, 52: 916-923. 10.1002/art.20935.
Article
CAS
PubMed
Google Scholar
Becker MA, Schumacher HR, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N: Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med. 2005, 353: 2450-2461. 10.1056/NEJMoa050373.
Article
CAS
PubMed
Google Scholar
Constitution of the United States: a history. [http://www.archives.gov/national-archives-experience/charters/constitution_history.html]